Patent Number: 6,165,493

Title: "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"

Abstract: A method for decreasing the frequency of transmission of human immunodeficiency virus or herpesviruses or for preventing the transmission of or treating a sexually transmitted bacterial infection by administering to a human an anti-human immunodeficiency virus amount or an anti-herpesvirus amount or an anti-bacterial amount of cellulose acetate phthalate (CAP) or hydroxypropyl methylcellulose phthalate (HPMCP), such as in micronized form, or a combination thereof, either alone or in combination with a pharmaceutically acceptable carrier or diluent. The CAP and/or HPMCP may be employed as a suspension of micronized particles and may further contain a water miscible, non-solvent for CAP or HPMCP, such as glycerol.

Inventors: Neurath; Alexander Robert (New York, NY), Jiang; Shibo (Jackson Heights, NY), Debnath; Asim Kumar (New York, NY), Strick; Nathan (Oceanside, NY), Dow; Gordon Jay (Santa Rosa, CA)

Assignee: New York Blood Center, Inc.

International Classification: A61K 31/716 (20060101); A61K 31/717 (20060101); A61K 9/14 (20060101); A61F 013/02 (); A61F 006/06 (); A61F 006/14 (); A61K 009/70 (); A61K 009/16 ()

Expiration Date: 12/26/2017